Nitric oxide synthase expression and function in embryonic and adult cardiomyocytes

Microscopy Research and Technique

Volumn 55, Issue 4, 2001, Pages 259-269

  Bloch, Wilhelm ^a   Addicks, Klaus ^a   Hescheler, Jürgen ^b   Fleischmann, Bernd K ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM COMPOUNDS; CELL SIGNALING; HEART; MAMMALS;

CA 2+; CARDIOMYOCYTES; CARDIOMYOGENESIS; CELL SYSTEM; EMBRYONICS; HOMOEOSTASIS; MYOFIBRILLAR; NITRIC OXIDE SYNTHASES; SIGNALING MOLECULES; SYNTHASE EXPRESSION;

NITRIC OXIDE;

NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM HOMEOSTASIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; EMBRYO CELL; HEART FUNCTION; HEART MUSCLE CELL; METABOLIC REGULATION; MUSCLE DEVELOPMENT; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

MAMMALIA;

EID: 0035891453     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jemt.1175     Document Type: Article

References (155)

1. Abu-Soud HM, Feldman PL, Clark P, Stuehr DJ. 1994. Electron transfer in the nitric-oxide synthases: characterization of l-arginine analogues that block heme iron reduction. J Biol Chem 269:32318-32326.
2. Abu-Soud HM, Loftus M, Stuehr DJ. 1995. Subunit dissociation and unfolding of macrophage NO synthase: relationship between enzyme structure, prosthetic group binding, and catalytic function. Biochemistry 34:11167-11175.
3. Adderley SR, Fitzgerald DJ. 1999. Oxidative damage of cardiomyocytes is limited by extracellular regulated kinases 1/2-mediated induction of cyclooxygenase-2. J Biol Chem 274:5038-5046.
4. Addicks K, Bloch W, Feelisch M. 1994. Nitric oxide modulates sympathetic neurotransmission at the prejunctional level. Microsc Res Tech 29:161-168.
5. Albina JE, Cui S, Matero RB, Rerichner JS. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 150: 5080-5085.
6. 2+ channels in embryonic mouse heart. Circ Res 78:371-378.
7. Archer S. 1993. Measurement of nitric oxide in biological models. FASEB J 7:349-360.
8. Arnhold S, Andressen C, Bloch W, Mai JK, Addicks K. 1997. NO synthase is transiently expressed in embryonic mouse olfactory receptor neurons. Neurosci Lett 229:165-168.
9. Arnhold S, Klinz FJ, Bloch W, Hess A, Andressen C, Addicks K. 1999. Selective expression of the NOS II isoform during mouse vestibulocochlear receptorgenesis. Eur J Neurosci 11:2187-2193.
10. Balligand J-L, Ungureanu D, Kelly RA, Kobzik L, Michel T, Smith TW. 1993a. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91:2314-2319.
11. Balligand J-L, Kelly RA, Marsden PA, Smith TW, Michel T. 1993b. Control of cardiac muscle cell function by an endogenous nitric oxide signalling system. Proc Natl Acad Sci USA 90:347-351.
12. Balligand J-L, Ungureanu-Longrois D, Simmons WW, Pimental D, Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW, Michel T. 1994. Cytokine-indicible nitric oxide synthase (iNOS) expression in cardiac myocytes: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269:27580-27588.
13. Balligand J-L, Kobzik L, Han X, Kaye DM, Belhassen L, O'Hara DS, Kelly RA, Smith TW, Michel T. 1995a. Nitric oxide-dependent parasympathetic signalling is due to activation of constitutive endothelial (type III) nitric oxide synthase in cardiac myocytes. J Biol Chem 270:14582-14586.
14. Balligand J-L, Ungureanu-Longrois D, Simmons WW, Kobzik L, Lowenstein CJ, Lamas S, Kelly RA, Smith TW, Michel T. 1995b. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1β and IFN-γ. Am J Physiol 268:H1293-H1303.
15. Bates TE, Loesch A, Burnstock G, Clark JB. 1996. Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218:40-44.
16. Bayraktutan U, Yang ZK, Shah AM. 1998. Selective dysregulation of nitric oxide synthase type 3 in cardiac myocytes but not coronary microvascular endothelial cells of spontaneously hypertensive rat. Cardiovasc Res 38:719-726.
17. Belhassen L, Kelly RA, Smith TW, Balligand J-L. 1996. Nitric oxide synthase (NOS3) and contractile responsiveness to adrenergic and cholinergic agonists in the heart: regulation of NOS3 transcription in vitro and in vivo by cAMP in rat cardiac myocytes. J Clin Invest 97:1908-1915.
18. Bernier SG, Haldar S, Michel T. 2000. Bradykinin-regulated interactions of the MAP kinase pathway with endothelial nitric oxide synthase. J Biol Chem 275:30707-30715.
19. Bloch W, Hoever D, Reitze D, Kopalek L, Addicks K. 1995. Exogenously supplied nitric oxide influences the dilation of the capillary microvasculature in vivo. Agents Actions (Suppl) 45:151-156.
20. Bloch W, Klotz T, Sedlaczek P, Zumbe J, Engelmann U, Addicks K. 1998. Evidence for the involvement of endothelial nitric oxide synthase (eNOS) from smooth muscle cells in the erectile function of the human corpus cavernosum. Urol Res 26:129-135.
21. Bloch W, Fischer C, Dittrich R, Reiner M, Addicks K. 1999a. Proteinkinase C (PKC), Myosinleichtkettenkinase (MLCK) und Stickstoffmonoxid (NO) sind an der Rekrutierung von Caveolen und Vesikeln in myokardialen Kapillarendothelzellen beteiligt. Z Kardiol (abstr) 88:165.
22. Bloch W, Fleischmann BK, Lorke D, Andressen C, Hoppe B, Hescheler J, Addicks K 1999b. Nitric oxide synthase expression and role during cardiomyogenesis. Cardiovasc Res 43:675-684.
23. Bloch W, Mehlhorn U, Krahwinkel A, Reiner M, Dittrich M, Schmidt A, Addicks K. 2001. Ischemia increases detectable endothelial nitric oxide synthase in rat and human myocardium. Nitric Oxide 5:317-333.
24. Blottner D, Luck G. 1998. Nitric oxide synthase (NOS) in mouse skeletal muscle development and differentiated myoblasts. Cell Tissue Res 292:293-302.
25. Brady AJB, Poole-Wilson PA, Harding SE, Warren JB. 1992. Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia. Am J Physiol 263:H1963-H1966.
26. Brady AJB, Warren JB, Poole-Wilson PA, Williams TJ, Harding SE. 1993. Nitric oxide attenuates cardiac myocyte contraction. Am J Physiol 265:H176-H182.
27. Bredt DS, Hwang CE, Glatt C, Lowenstein C, Reed RR, Snyder SH. 1991. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351:714-718.
28. Butt E, Bernhardt M, Smolenski A, Kotsonis P, Fröhlich LG, Sickmann A, Meyer HE, Lohmann SM, Schmidt HHHW. 2000. Endothelial nitric-oxide synthase (type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J Biol Chem 275:5179-5187.
29. Campbell DL, Stamler JS, Strauss HC. 1996. Redox modulation of L-type calcium channels in ferret ventricular myocytes. Dual mechanism regulation by nitric oxide and S-nitrosothiols. J Gen Physiol 108:277-293.
30. Chen Z, Mitchelhill KI, Michell BJ, Stapleton D, Rodriguez-Crespo I, Witters LA, Power DA, Ortiz de Montellano PR, Kemp BE. 1999. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett 443:285-289.
31. Chilian WM, Kuo L, DeFily DV, Jones CJ, Davis MJ. 1993. Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions. Eur Heart J 14(Suppl I):55-59.
32. Cleeter MWJ, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AHV. 1994. Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases. FEBS Lett 345: 295-298.
33. Davidge SD, Baker PN, McLaughlin MK, Roberts JM. 1995. Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circ Res 77:274-283.
34. de Belder AJ, Radomski MW, Why HJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S. 1993. Nitric oxide synthase activities in human myocardium. Lancet 341:84-85.
35. Depre C, Fierain L, Hue L. 1997. Activation of nitric oxide synthase by ischaemia in the perfused heart. Cardiovasc Res 33:82-88.
36. De Vera ME, Shapiro RA, Nussler AK, Mudgett JS, Simmons RL, Morris SM, Billiar TR, Geller GA. 1996. Transcriptional regulation of human inducible nitric oxide synthase (NOS″) gene by cytokines: initial analysis of the human NOS2 promotor. Proc Natl Acad Sci USA 93:1054-1059.
37. de Weerd WF, Leeb-Lundberg LM. 1997. Bradykinin sequesters B2 bradykinin receptors and the receptor-coupled Galpha subunits Galphaq and Galphai in caveolae in DDT1 MF-2 smooth muscle cells. J Biol Chem 272:17858-17866.
38. Dimmeler S, Ankarcrona M, Nicotera P, Brune B. 1993. Exogenous nitric oxide (NO) generation or IL-1 beta-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells. J Immunol 150:2964-2971.
39. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. 1999. Activation of nitric oxide synthase in endothelial cells by AKT-dependent phosphorylation. Nature 399:601-605.
40. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R. 1985. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. J Embryol Exp Morphol 87:27-45.
41. Elvan A, Rubart M, Zipes DP. 1997. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol 272:H263-H271.
42. Feelisch M, Bloch W, Addicks K. 1995. Control of intraaxonal catecholamine storage in cardiac sympathetic nerve fibers by endogenous nitric oxide. Editors, S Moncada, M Feelisch, R Busse, EA Higgs. The biology of nitric oxide, part 3. London: Portland Press. p 299-302.
43. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. 1996. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814.
44. Feron O, Dessy C, Opel DJ, Arstall MA, Kelly RA, Michel T. 1998. Modulation of the endothelial nitric-oxide synthase-caveolin interaction in cardiac myocytes. J Biol Chem 273:30249-30254.
45. Feron O, Han X, Kelly RA. 1999a. Muscarinic cholinergic signalling in cardiac myocytes: dynamic targeting of M2AChR to sarcolemmal caveolae and eNOS activation. Life Sci 64:471-477.
46. Feron O, Dessy C, Moniotte S, Desager J-P, Balligand J-L. 1999b. Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897-905.
47. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simons RL. 1992. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 257:387-389.
48. Finkel MS, Oddis CV, Mayer OH, Hattler BG, Simmons RL. 1995. Nitric oxide synthase inhibitor alters papillary muscle force-frequency relationship. J Pharmacol Exp Ther 272:945-952.
49. Fischmeister R, Hartzell HC. 1986. Mechanism of action of acetylcholine on calcium current in single cells from frog ventricle. J Physiol Lond 376:183-202.
50. Fischmeister R, Hartzell HC. 1987. Cyclic guanosine 3′,5′-monophosphate regulates the calcium current in single cells from frog ventricle. J Physiol Lond 387:453-472.
51. Förstermann U, Schmidt HHHW, Pollock JS, Sheng H, Mitchell JA, Warner TD, Nakane MM, Murad F. 1991. Isoforms of nitric oxide synthase. Characterization and purification from different cell types. Biochem Pharmacol 42:1849-1857.
52. Förstermann U, Boissel J-P, Kleinert H. 1998. Expressional control of the constitutive isoforms of nitric oxide synthase (NOSI and NOSIII). FASEB J 12:773-790.
53. Fukuchi M, Hussain SNA, Giaid A. 1998. Heterogenous expression and activity of endothelial and inducible nitric oxide synthases in end-stage human heart failure. Their relation to lesion site and β-adrenergic receptor therapy. Circulation 98:132-139.
54. Fulton D, Gratton JP, McGcabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. 1999. Regulation of endothelium-derived nitric oxide production by protein kinase AKT. Nature 399:597-601.
55. Garcia-Gardena G, Martasek P, Sue Siler Masters B, Skidd PM, Couet J, Li S, Lisanti MP, Sessa WC. 1997. Dissecting the interaction between nitric oxide synthase (NOS) and caveolin. J Biol Chem 272:25437-25440.
56. Gauthier C, Leblais V, Kobzik L, Trochu J-N, Khandoudi N, Balligand J-L, Le Marec H. 1998. The negative inotropic effect of β3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle. J Clin Invest 102:1377-1384.
57. Haasemann M, Cartaud J, Müller-Esterl W, Dunia I. 1998. Agonist-induced redistribution of bradykinin B2 receptor in caveolae. J Cell Sci 111:917-928.
58. Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM. 1996. Tumor necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet 347:1151-1155.
59. Haddad GE, Sperelakis N, Bkaily G. 1995. Regulation of the calcium slow channel by cyclic GMP dependent protein kinase in chick heart cells. Mol Cell Biochem 148:89-94.
60. Han X, Shimoni Y, Giles WR. 1994. An obligatory role for nitric oxide in autonomic control of mammalian heart rate. J Physiol Lond 476:309-314.
61. Han X, Shimoni Y, Giles WR. 1995. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J Gen Physiol 106:45-65.
62. Han X, Kobzik L, Severson D, Shimoni Y. 1998a. Characteristics of nitric oxide-mediated cholinergic modulation of calcium current in rabbit sino-atrial node. J Physiol 509:741-754.
63. Ca-1 is absent in mice with targeted disruption of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 95:6510-6515.
64. Hare JM, Stamler JS. 1999. NOS:modulator, not mediator of cardiac performance. Nature Med 5:273-274.
65. Hare JM, Kim B, Flavahan NA, Ricker KM, Peng X, Colman L, Weiss RG, Kass DA. 1998. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J Clin Invest 101:1424-1431.
66. 2+ current in single heart cells. Nature 323:273-275.
67. Haywood GA, Tsao PS, von der Leyen HE, Mann MJ, Keeling PJ, Trindade PT, Lewis NP, Byrne CD, Rickenbacher PR, Bishopric NH, Cooke JP, McKenna WJ, Fowler MB. 1996. Expression of inducible nitric oxide synthase in human heart failure. Circulation 93:1087-1094.
68. Hescheler J, Kameyama M, Trautwein W. 1986. On the mechanism of muscarinic inhibition of the cardiac Ca current. Pflugers Arch 407: 182-189.
69. Hohenegger M, Suko J. 1993. Phosphorylation of the purified cardiac ryanodine receptor by exogenous and endogenous protein kinases. Biochem J 296:303-308.
70. Hove Madsen L, Mery PF, Jurevicius J, Skeberdis AV, Fischmeister R. 1996. Regulation of myocardial calcium channels by cyclic AMP metabolism. Basic Res Cardiol 91(Suppl 2):1-8.
71. 2+ channels by s-nitrosothiol nitric oxide donors. Circ Res 81:742-752.
72. Ientile R, Malecka B, Picciurro V, Naso A, Pedale S, Macaione S. 1996. Nitric oxide synthase in chick embryo retina during development. FEBS Lett 379:82-84.
73. Igarashi J, Nishida M, Hoshida S, Yamashita N, Kosaka H, Hori S, Kuzuya T, Tada M. 1998. Inducible nitric oxide synthase augments injury elicited by oxidative stress in rat cardiac myocytes. Am J Physiol 274:0245-0252.
74. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad USA 84:9265-9269.
75. Ikeda U, Shimada K. 1997. Nitric oxide and cardiac failure. Clin Cardiol 20:837-841.
76. Ikeda U, Maeda Y, Kawahara Y, Yokoyama M, Shimada K. 1995. Angiotensin II augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. Circulation 92:2683-2689.
77. Ikeda U, Yamamoto K, Ichida M, Ohkawa F, Murata M, Iimura O, Kusano E, Asano Y, Shimada K. 1996. Cyclic AMP augments cytokine-stimulated nitric oxide synthesis in rat cardiac myocytes. J Mol Cell Cardiol 28:789-795.
78. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S. 1995. Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92:4392-4396.
79. 2+-channel during cardiomyogenesis: switch from NO to adenylyl cyclase mediated inhibition. FASEB J 13(2):313-324.
80. Ju H, Zou R, Venema VJ, Venema RC. 1997. Direct interaction of endothelial nitric-oxide synthase and caveolin-1 inhibits synthase activity. J Biol Chem 272:18522-18525.
81. Ju H, Venema VJ, Marrero MB, Venema RC. 1998. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J Biol Chem 273:24025-24029.
82. Kacimi R, Long CS, Karliner JS. 1997. Chronic hypoxia modulates the interleukin-1beta-stimulated inducible nitric oxide synthase pathway in cardiac myocytes. Circulation 96:1937-1943.
83. Kan H, Xie Z, Finkel MS. 1999. Norepinephrine-stimulated MAP kinase activity enhances cytokine-induced NO production by rat cardiac myocytes. Am J Physiol 276:H47-H52.
84. Kaye DM, Wiviott SD, Balligand J-L, Simmons WW, Smith TW, Kelly RA. 1996. Frequency-dependent activation of a constitutive nitric oxide synthase and regulation of contractile function in adult rat ventricular myocytes. Circ Res 78:217-224.
85. 2+-independent manner in cardiac myocytes: role of troponin I phosphorylation. Biochem Biophs Res Commun 256:398-403.
86. Kelly RA, Balligand J-L, Smith TW. 1996. Nitric oxide and cardiac function. Circ Res 79:363-380.
87. Kerwin JF, Heller M. 1994. The arginine-nitric oxide pathway: a target for new drugs. Med Res Rev 14:23-74.
88. Kinugawa K, Shimizu T, Yao A, Kohmoto O, Serizawa T, Takahashi T. 1997. Transcriptional regulation of inducible nitric oxide synthase in cultured neonatal rat cardiac myocytes. Circ Res 81:911-921.
89. Kuzin B, Roberts I, Peunova N, Enikolopov G. 1996. Nitric oxide regulates cell proliferation during drosophilia development. Cell 87:639-649.
90. Lamas S, Mardsen PA, Li GK, Tempst P, Michel T. 1992. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 89: 6348-6352.
91. Lancaster JR, Hibbs JB. 1990. EPR demonstration of iron-nitrosyl complex formatio ide synthase in human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93:720-729.
92. LaPointe MC, Isenovic E. 1999. Interleukin-1 beta regulation of inducible nitric oxide synthase and cyclooxygenase-2 involves the p42/44 and p38 MAPK signalling pathways in cardiac myocytes. Hypertension 33:276-282.
93. Lewis NP, Tsao PS, Rickenbacher PR, Xue C, Johns RA, Haywood GA, von der Leven H, Trindade PT, Cooke JP, Hunt SA, Billingham ME, Valantine HA, Fowler MB. 1996. Induction of nitric oxide synthase in human cardiac allograft is associated with contractile dysfunction of the left ventricle. Circulation 93:720-729.
94. Liu J, Hughes TE, Sessa W. 1997. The first amino acids and fatty acylation sites determine the molecular targeting of endothelial nitric oxide synthase into the golgi region of cells: a green fluorescent protein study. J Cell Biol 137:1525-1535.
95. Maltsev VA, Ji GJ, Wobus AM, Fleischmann BK, Hescheler J. 1998. Establishment of b-adrenergic modulation of L-type calcium current in the early stages of cardiomyocyte development. Circ Res 84:136-145.
96. Marietta MA. 1993. Nitric oxide synthase structure and mechanism. J Biol Chem 268:12231-12234.
97. Martynyuk AE, Kane KA, Cobbe SM, Rankin AC. 1996. Nitric oxide mediates the anti-adrenergic effect of adenosine on calcium current in isolated rabbit atrioventricular nodal cells. Pflugers Arch 431: 452-457.
98. McDonald KK, Zharikov S, Block ER, Michael MS. 1997. A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox." J Biol Chem 272:31312-31216.
99. Mery PF, Pavoine C, Belhassen L, Pecker F, Fischmeister R. 1993. Nitric oxide regulates cardiac Ca2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 268:26286-26295.
100. Mery PF, Abi-Gerges N, Vandecasteele G, Jurevivius J, Eschenhagen T, Fischmeister R. 1997. Muscarinic regulation of the L-type calcium current in isolated cardiac myocytes. Life Sci 60:1113-1120.
101. Michel T, Feron O. 1997. Nitric oxide syntheses: Which, where, how, and why? J Clin Invest 100:2146-2152.
102. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. 1997. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J Biol Chem 272:25907-25912.
103. Moncada S. 1992. The L-arginine: Nitric oxide pathway. Acta Physiol Scand 145:201-227.
104. Moncada S, Palmer RNJ, Higgs EA. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 43:109-142.
105. Nakane M, Schmidt HH, Pollock JS, Forstermann U, Murad F. 1993. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 316:175-180.
106. Nathan C, Xie Q-W. 1994a. Regulation of biosynthesis of nitric oxide. J Biol Chem 269:13725-13728.
107. Nathan C, Xie QW. 1994b. Nitric oxide synthases: roles, tolls, and controls. Cell 78:915-918.
108. Oddis CV, Finkel MS. 1996. NF-kappa B and GTP cyclohydrolase regulate cytokine-induced nitric oxide production by cardiac myocytes. Am J Physiol 270:H1864-1868.
109. Oddis CV, Simmons RL, Hattler BG, Finkel MS. 1995. cAMP enhances inducible nitric oxide synthase mRNA stability in cardiac myocytes. Am J Physiol 269:H2044-H2050.
110. Oddis CV, Simmons RL, Hattler BG, Finkel MS. 1996. Protein kinase A activation is required for IL-1-induced nitric oxide production by cardiac myocytes. Am J Physiol 271:C429-C434.
111. Palmer RMJ, Ferrige AG, Moncada S. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 327:524-526.
112. Peunova N, Enikolopov G. 1995. Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 375: 68-73.
113. Pinson A, Halabi A, Shohami E. 1992. Mechanical injury increases eicosanoid production in cultured cardiomyocytes. Prostaglandins Leukot Essent Fatty Acids 46:9-13.
114. 2+ pump of bovine pulmonary artery. Cell Calcium 11:261-268.
115. Robinson LJ, Weremowicz S, Morton CC, Michel T. 1994. Isolation and chromosomal localization of the human endothelial nitric oxide synthase (NOS3) gene. Genomics 19:350-357.
116. Ruskoaho H, Leskinen H, Magga J, Taskinen P, Mäntymaa Vuolteenaho O, Leppäluoto J. 1997. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J Mol Med 75:876-885.
117. Schini VB, Busse R, Vanhoutte PM. 1994. Inducible nitric oxide synthase in vascular smooth muscle. Drug Res 44:432-435.
118. Schultz G, Rosenthal W, Hescheler J, Trautwein W. 1990. Role of G proteins in calcium channel modulation. Annu Rev Physiol 52:275-292.
119. Schulz R, Nava E, Moncada S. 1992. Induction and potential biological relevance of a calcium-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105:575-580.
120. Schwarz P, Diem R, Dun NJ, Förstermann U. 1995. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ Res 77:841-848.
121. Schweizer M, Richter C. 1994. Nitric oxide potently and reversibly deenergizes mitochondria at low oxygen tension. Biochem Biophys Res Commun 204:169-175.
122. Seilicovich A, Lasaga M, Befumo M, Duvilanski BH, del Carmen Diaz M, Rettori V, McCann SM. 1995. Nitric oxide inhibits the release of norepinephrine and dopamine from the medial basal hypothalamus of the rat. Proc Natl Acad Sci USA 92:11299-11302.
123. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson GW, Michel T. 1996. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522.
124. Shimoni Y, Han X, Severson D, Giles WR. 1996. Mediation by nitric oxide of the indirect effects of adenosine on calcium current in rabbit heart pacemaker cells. Br J Pharmacol 119:1463-1469.
125. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. 1996a. Cytokines and insulin induce cationic amino acid transporter expression in cardiac myocytes: regulation of L-arginine transport and NO production by CAT-1, CAT-2A and CAT-2B. J Biol Chem 271:11694-11702.
126. Simmons WW, Ungureanu-Longrois D, Smith GK, Smith TW, Kelly RA. 1996b. Glucocorticoids regulate inducible nitric oxide synthase (NOS2) by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem 271:23928-23937.
127. Singh K, Balligand J-L, Fischer TA, Smith TW, Kelly RA. 1995. Glucocorticoids increase osteopontin expression in cardiac myocytes and microvascular endothelial cells: role in regulation of inducible nitric oxide synthase. J Biol Chem 270:28471-28478.
128. Slotkin TA, Lau C, Seidler FJ. 1994. Beta-adrenergic receptor over-expression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins. Toxicol Appl Pharmacol 129:223-234.
129. Stoyanovsky D, Murphy T, Anno PR, Kim Y-M, Salama G. 1997. Nitric oxide activates skeletal and cardiac ryanodine receptors. Cell Calcium 21:19-29.
130. Su Z, Blazing MA, Fan D, George SE. 1995. The calmodulin-nitric oxide synthase interaction: critical role of the calmodulin latch domain in enzyme activation. J Biol Chem 270:28117-29122.
131. 2+ current in rat ventricular myocytes. Circ Res 77:803-812.
132. Takasago T, Imagawa T, Furukawa K, Shigekawa M. 1991. Regulation of the cardiac ryanodine receptor by protein kinase-dependent phospholylation. J Biochem 109:163-170.
133. Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271:2255-2261.
134. Teng B, Murthy KS, Kuemmerle JF, Grider JR, Sase K, Michel T, Makhlouf GM. 1998. Expression of endothelial nitric oxide synthase in human and rabbit gastrointestinal smooth muscle cells. Am J Physiol 275:G342-G351.
135. Tohse N, Sperelakis N. 1991. cGMP inhibits the activity of single calcium channels in embryonic chick heart cells. Circ Res 69:325-331.
136. Trautwein W, Hescheler J. 1990. Regulation of cardiac L-type calcium current by phosphorylation and G proteins. Annu Rev Physiol 52: 257-274.
137. Ungureau-Longrois D, Balligand J-L, Simmons WW, Okada I, Kobzik L, Lowenstein CJ, Kunkel SL, Michel T, Kelly RA, Smith TW. 1995. Induction of nitric oxide synthase activity by cytokines in ventricular myocytes is necessary but not sufficient to decrease contractile responsiveness to β-adrenergic agonists. Circ Res 77:494-502.
138. Vandecasteele G, Eschenhagen T, Scholz H, Stein B, Verde I, Fischmeister R. 1999. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase. Nature Med 5:331-334.
139. Venema VJ, Marrero MB, Venema RC. 1996. Bradykinin-stimulated protein tyrosine phosphorylation promotes endothelial nitric oxide synthase translocation to the cytoskeleton. Biochem Biophys Res Commun 226:703-710.
140. Venema VJ, Zou R, Ju H, Marrero MB, Venema RC. 1997. Caveolin-1 detergent solubility and association with endothelial nitric oxide synthase is modulated by tyrosine phosphorylation. Biochem Biophys Res Commun 236:155-161.
141. Vila-Petroff MG, Younes A, Egan J, Lakatta EG, Sollott SJ. 1999. Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. Circ Res 84:1020-1031.
142. Wariishi S, Miyahara K, Toda K, Ogoshi S, Doi Y, Ohnishi S, Mitsui Y, Yui Y, Kawai C, Shizuta Y. 1995. A SP1 binding site in the GC-rich region is essential for core promoter activity of the human endothelial nitric oxide synthase gene. Biochem Biophys Res Commun 216:729-735.
143. 2+ channel blockers. Differentiation 48: 173-182.
144. Worrall NK, Chang K, Suau GM, Allison WS, Misko TP, Sullivan PM, Tilton RG, Williamson JR, Ferguson TB. 1996. Inhibition of inducible nitric oxide synthase prevents graft and systemic vascular barrier dysfunction early cardiac allograft rejection. Circ Res 78: 769-779.
145. Xie Q, Nathan C. 1994. The high-output nitric oxide pathway: role and regulation. J Leukoc Biol 56:576-582.
146. Xie QW, Cho HJ, Calaycay J, Mumford RA, Swiderek KM, Lee TD, Ding A, Troso T, Nathan C. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225-228.
147. Xie YW, Shen W, Zhao G, Xu X, Wolin MS, Hintze TH. 1996. Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Circ Res 79:381-387.
148. Xu KY, Huso DL, Dawson TM, Bredt DS, Becker LC. 1999. Nitric oxide synthase incardiac sarcoplasmic reticulum. Proc Natl Acad Sci USA 96:657-662.
149. Xu L, Eu JP, Meissner G, Stamler JS. 1998. Activation of the cardiac calcium release channel (ryanodine receptor) by poly-S-nitrosylation. Science 279:234-237.
150. Yamamoto K, Ikeda U, Shimada K. 1997. Natriuretic peptides modulate nitric oxide synthesis in cytokine-stimulated cardiac myocytes. J Mol Cell Cardiol 29:2375-2382.
151. Yamamoto K, Dang QN, Kelly RA, Lee RT. 1998. Mechanical strain suppresses inducible nitric-oxide synthase in cardiac myocytes. J Biol Chem 273:11862-118666.
152. Yasuda S, Lew WY. 1997. Lipopolysaccharide depresses cardiac contractility and beta-adrenergic contractile response by decreasing myonlament response to Ca2+ in cardiac myocytes. Circ Res 81: 1011-1020.
153. Zahradnikova A, Minarovic I, Venema RC, Meszaros LG. 1997. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22:447-453.
154. Zhang J, Snyder SH. 1995. Nitric oxide in the nervous system. Annu Rev Pharmacol Toxicol 35:213-233.
155. Zhang R, Min W, Sessa WC. 1995. Functional analysis of the human endothelial nitric oxide synthase promotor: SP1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 270:15320-15326.